The Detection of Fosfomycin-Modifying Enzymes (fos) in Uropathogenic Enterobacterale, Azerbaijan, Iran.

Aidin Lalezadeh, Pardis Ghotaslou, Reza Ghotaslou
Author Information
  1. Aidin Lalezadeh: Department of Microbiology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. ORCID
  2. Pardis Ghotaslou: Students' Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran. ORCID
  3. Reza Ghotaslou: Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. ORCID

Abstract

is the most common agent of urinary tract infections (UTIs). Multidrug resistant (MDR) and XDR (extensively drug-resistant) Enterobacteriaceae in UTIs have increased in the world. The present study aimed to study the fosfomycin resistance frequency and the fosfomycin resistance genes among Enterobacteriaceae isolated from UTIs. The urine was collected and cultured in the standard protocol. To determine the susceptibility testing to fosfomycin in 211 isolates, agar dilution and disk agar diffusion methods were used. MDR was nonsusceptibility to at least one agent in three or more antimicrobial categories. The fosfomycin resistance genes were also evaluated by PCR. The frequency of resistance to fosfomycin was in 14 (6.6%) and 15 (7.1%) isolates by the disk agar diffusion and MIC assays, respectively. However, the MIC and MIC existed at 8 g/mL and 16 g/mL, respectively. The MDR was found in 80%. The frequencies of fosfomycin resistance genes were 5 (33.3%), 3 (20%), 2 (13.3%), 1 (6.6%), and 1 (6.6%) for fosC, fosX, fosA3, fosA, and fosB2, respectively. The fosB and fosC2 were not found. A low resistance rate to fosfomycin is observed. Fosfomycin is still one of the most effective and valuable alternative antibiotics against MDR isolated from UTIs in our region.

References

  1. Pathogens. 2022 Jan 26;11(2): [PMID: 35215097]
  2. Ann Clin Microbiol Antimicrob. 2021 Apr 27;20(1):32 [PMID: 33906654]
  3. Front Cell Infect Microbiol. 2017 Jun 08;7:241 [PMID: 28642845]
  4. Iran J Microbiol. 2016 Apr;8(2):125-31 [PMID: 27307978]
  5. Acc Chem Res. 2021 May 4;54(9):2055-2064 [PMID: 33788541]
  6. Int J Antimicrob Agents. 2010 Mar;35(3):240-3 [PMID: 20034765]
  7. Microb Drug Resist. 2017 Oct;23(7):826-832 [PMID: 28151044]
  8. PLoS One. 2021 Jan 6;16(1):e0244673 [PMID: 33406110]
  9. Mol Biol Rep. 2018 Oct;45(5):1055-1065 [PMID: 30008141]
  10. Infect Drug Resist. 2021 Sep 07;14:3647-3658 [PMID: 34522107]
  11. Biotechnol Rep (Amst). 2021 Sep 24;32:e00677 [PMID: 34631437]
  12. Can J Infect Dis Med Microbiol. 2013 Fall;24(3):e80-2 [PMID: 24421836]
  13. Appl Microbiol Biotechnol. 2021 Dec;105(23):8881-8893 [PMID: 34724083]
  14. Int J Infect Dis. 2011 Nov;15(11):e732-9 [PMID: 21945848]
  15. Antimicrob Agents Chemother. 2012 Apr;56(4):2135-8 [PMID: 22232290]
  16. J Med Microbiol. 2016 Nov;65(11):1322-1331 [PMID: 27655293]
  17. Front Microbiol. 2022 Jan 27;12:813145 [PMID: 35154037]
  18. Infect Dis Ther. 2017 Jun;6(2):233-243 [PMID: 28285420]
  19. Int J Infect Dis. 2009 Mar;13(2):140-4 [PMID: 18703368]
  20. Clin Infect Dis. 2008 Apr 1;46(7):1069-77 [PMID: 18444827]
  21. J Med Microbiol. 2013 Nov;62(Pt 11):1707-1713 [PMID: 23988630]
  22. Antimicrob Agents Chemother. 2015 Oct;59(10):6597-600 [PMID: 26169417]
  23. Int J Antimicrob Agents. 2017 Jul;50(1):29-34 [PMID: 28456703]
  24. Hippokratia. 2013 Oct;17(4):355-8 [PMID: 25031516]
  25. Microbiol Spectr. 2022 Aug 31;10(4):e0054522 [PMID: 35852324]
  26. J Trop Med. 2021 Jul 12;2021:9195184 [PMID: 34335793]
  27. J Antimicrob Chemother. 2012 Dec;67(12):2843-7 [PMID: 22893681]
  28. J Antimicrob Chemother. 2016 Sep;71(9):2563-8 [PMID: 27246234]
  29. J Infect Public Health. 2021 Jan;14(1):131-138 [PMID: 33234410]
  30. Clin Microbiol Infect. 2012 Jan;18(1):4-7 [PMID: 21914036]
  31. J Antimicrob Chemother. 2010 Nov;65(11):2459-63 [PMID: 20851815]

Word Cloud

Created with Highcharts 10.0.0fosfomycinresistanceUTIsMDRgenesagar66%MICrespectivelyagentEnterobacteriaceaestudyfrequencyisolatedisolatesdiskdiffusiononefound3%1commonurinarytractinfectionsMultidrugresistantXDRextensivelydrug-resistantincreasedworldpresentaimedamongurinecollectedculturedstandardprotocoldeterminesusceptibilitytesting211dilutionmethodsusednonsusceptibilityleastthreeantimicrobialcategoriesalsoevaluatedPCR141571%assaysHoweverexisted8 g/mL16 g/mL80%frequencies533320%213fosCfosXfosA3fosAfosB2fosBfosC2lowrateobservedFosfomycinstilleffectivevaluablealternativeantibioticsregionDetectionFosfomycin-ModifyingEnzymesfosUropathogenicEnterobacteraleAzerbaijanIran

Similar Articles

Cited By

No available data.